Efficacy Study of Different Lens Treatments on Chinese Adolescent Myopia
DLTCAM
Randomized Controlled Trial of Different Lens Treatments on Chinese Adolescent Myopia
1 other identifier
interventional
120
1 country
1
Brief Summary
The purpose of this study is to determine the efficacy of different lens treatments (normal spectacle lens, ortho-K, \& Myovision) on myopia control in Chinese adolescent patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2013
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2013
CompletedFirst Submitted
Initial submission to the registry
November 23, 2013
CompletedFirst Posted
Study publicly available on registry
December 4, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2016
CompletedApril 25, 2016
April 1, 2016
2.8 years
November 23, 2013
April 21, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change of Ocular Axial Length
Ocular axial length (AL), which increases with age, will be measured 3 times by an IOLMaster. The first AL examination was considered as the baseline data, and will be repeated 6 and 12 months later.
Baseline, 6 months, 12 months
Secondary Outcomes (1)
Change of Spherical Equivalent Refraction
Baseline, 6 months, 12 months
Study Arms (3)
Spectacles
ACTIVE COMPARATORSpectacles are the most common lens treatment to correct myopia. This arm is set to be as a control group for the other two arms. Myopia patients who enter in this group will wear a normal pair of glasses after the baseline examinations (axial length, refraction...).
Myovison
ACTIVE COMPARATORMyovision is a kind of specially designed, commercially available spectacle lenses that could control the peripheral refraction of myopia patients. Latest studies have changed the understanding of myopia--correcting both central and peripheral vision during lens treatment is indicating to be an effective way of slowing down eye growth. Patients who entered this group will wear a pair of Myovision after baseline examinations.
Ortho-K
ACTIVE COMPARATOROrthokeratology has recently been reported as an effective way to control eye growth for myopia adolescents. Patents who enter this group will wear ortho-K lenses during sleep after baseline examinations.
Interventions
Myovision is a kind of specially designed spectacle glasses that could control the peripheral refraction of myopia patients. It is commercially available.
Eligibility Criteria
You may qualify if:
- Adolescent myopia patients
- Myopic refraction between -1.00D and -4.50D
- Astigmatism equal or less than -1.50D
- Normal break up time of tear film (BUT \> 10s)
You may not qualify if:
- Existence of any ocular diseases except ametropia
- Hyperopia
- Severe dry eye
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ophthalmology Department of Peking University People's Hospital
Beijing, 100044, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kai Wang, Dr.
Peking University People's Hospital
Central Study Contacts
Xi Rong Wu, Dr.
CONTACT
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 23, 2013
First Posted
December 4, 2013
Study Start
November 1, 2013
Primary Completion
September 1, 2016
Study Completion
September 1, 2016
Last Updated
April 25, 2016
Record last verified: 2016-04